Celltrion Healthcare presents the first real-world data for Truxima® (biosimilar rituximab) in patients with diffuse large B-cell lymphoma at the EHA 2021 Virtual Congress – Business Wire

CONTEXT:  Presentation at the European Hematology Association (EHA) 2021 Virtual Congress of a post-approval safety study on Truxima (biosimiliar rituximab) in patients with large B-cell lymphoma.  Results showed similar results Continue Reading

Posted On :

Results from IMBRUVICA® (ibrutinib) RESONATE-2 Study Provide Up to Seven Years of Progression-Free and Overall Survival Data in First-Line Chronic Lymphocytic Leukemia (CLL) – PRNewswire

CONTEXT:  Report of new data to be presented by Abbvie at the European Hematology Association (EHA) Virtual Congress derived from the informCLLTM registry assessing how real-word treatment patterns align with Continue Reading

Posted On :

ASCO 2021 Podium Presentation on Agendia FLEX Study Shows Clinical & Molecular Differences in Tumors of African American and Caucasian Patients with HR+ Breast Cancer – BioSpace

CONTEXT:  We’ve covered reports around this theme before, so good to see further research supporting why it is important to have representative ethnic diversity in all studies on new therapies, Continue Reading

Posted On :

Syapse Announces New Real-World Data Studies Published at 2021 American Society for Clinical Oncology Annual Meeting – Yahoo Finance Australia

CONTEXT:  Report of one poster presentation and four abstracts derived from Synapse’ RWD capabilities at ASCO 2021.  Further evidence of RWD becoming an increasingly valuable tool for oncology research. IMPACT: Continue Reading

Posted On :

Target RWE Research Presented at DDW 2021 Shows High Rates of Biologic Combination Therapy and Previous Biologic Exposure in IBD Population – PRNewswire

CONTEXT:  RWE data presented at the Digestive Disease Week (DDW) 2021 evaluated the prevalence and predictors of immunomodulator use as concomitant therapy with two commonly prescribed biologics.   IMPACT:  Low Continue Reading

Posted On :

Late Breaking Data at EuroPCR Demonstrates Long-Term Benefits of Medtronic Radiofrequency Renal Denervation in Real-World Hypertensive Patients – PRNewswire

CONTEXT:  Report of data presented at the EuroPCR annual meeting on Medtronic’s Symplicity Renal Denervation system.  Results from a registry involving nearly 3,000 patients showed significant and clinically meaningful reductions Continue Reading

Posted On :